What is Caduceus?
Caduceus Corporation is dedicated to advancing the treatment of pulmonary and sleep disorders, including conditions such as asthma, COPD, obstructive sleep apnea, and pulmonary fibrosis. Operating from St. Louis, Missouri, the company provides essential diagnostic services like blood gas analysis, bronchoscopy, and pulmonary function tests. Their core mission revolves around enhancing patient health and safety through specialized medical care and maintaining highly sanitized facilities for individuals suffering from respiratory and sleep-related ailments.
How much funding has Caduceus raised?
Caduceus has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Caduceus?
The recent strategic investment in Caduceus signals a strong validation of its business model and market potential within the specialized field of pulmonary and sleep medicine. As a late-stage company, this financing is likely to fuel further expansion of its services, potentially through enhanced diagnostic capabilities, broader patient outreach, or the development of new treatment protocols. The company's focus on critical health conditions positions it for continued growth and impact in the healthcare landscape.
See full Caduceus company page
